In addition to this story being interesting, it highlights how reproducibility is so seldom tested in the current constrained funding environment. In fact it seems that this situation is particularly true of the whole field of stem cell biology...
“What anyone publishes is not really the corpus of scientific knowledge unless it can be verified,” says Gosden. “You don't get a paradigm change until you have a consensus of expert opinion,” he says, and that is certainly not the case here. This follows physicist and science historian Thomas Kuhn's view of scientific revolutions—that many inconsistencies must build up in a field of science before a paradigm shift can occur.
The Kuhn model of paradigm shifts describes how most central ideas in science get revised or overturned, but there is another model that some would argue is equally valid, if rarer: the “lone voice in the wilderness” of a single scientist pushing a revolutionary idea forward. There are notable examples of lone voices who both succeeded and failed in overturning an idea. Stanley Prusiner's hypothesis that aberrant protein structures called prions could cause infection initially lost him his bid for tenure at the University of California at San Francisco and significant funding from the Howard Hughes Medical Institute, but eventually won him a Nobel prize in physiology or medicine in 1997. The cold fusion work of the late 1980s, which was never replicated to the satisfaction of the nuclear physics community, eventually resulted in Martin Fleischmann and Stanley Pons dropping out of academia.
“There's a fine line between being a maverick and a genius prescient person,” says Durant. Currently, Tilly is gingerly straddling that line, which can mean the difference between receiving the highest scientific honors or the scorn of your peers."
1 comments:
It's interesting to note that it took no time at all for the initial induced pluripotent stem cells (iPS) claim to be verified by several labs. This also within the high-powered, high-technology field of stem cell biology.
Doesn't this suggest that "limited funding" is not the issue here?
Post a Comment